https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Pancreatic enzyme replacement therapy in cystic fibrosis: Australian guidelines https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:12951 Sat 24 Mar 2018 08:18:29 AEDT ]]> Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26225 Fri 03 Dec 2021 10:33:00 AEDT ]]>